Trial intelligence / Profile preview

Low-Dose Radiotherapy for COVID-19 Pneumonia

NCT04380818Unknown

Sponsor
GICOR
Start
Jun 2020
Primary completion
Sep 2021
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by GICOR. Primary endpoint: Change in PAFI O2 at Day 2. Status: unknown.

Beyond the preview

Go deeper on NCT04380818.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04380818.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call